汪贻广/陈斌龙团队开发一种溶酶体-线粒体级联靶向纳米策略高效调控肿瘤焦亡

中国药学(英文版) ›› 2025, Vol. 34 ›› Issue (2): 188-189.

汪贻广/陈斌龙团队开发一种溶酶体-线粒体级联靶向纳米策略高效调控肿瘤焦亡

北京大学药学院天然药物及仿生药物全国重点实验室

北京大学药学院天然药物及仿生药物全国重点实验室

收稿日期:2025-01-19 修回日期:2025-01-19 接受日期:2025-01-19 出版日期:2025-03-01 发布日期:2025-03-03

The research teams of Prof. Yiguang Wang/Prof. Binlong Chen have developed lysosome-mitochondria cascade targeting nanoparticle drives robust pyroptosis for cancer immunotherapy

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2025-01-19 Revised:2025-01-19 Accepted:2025-01-19 Online:2025-03-01 Published:2025-03-03

摘要/Abstract

摘要：

2024年12月5日, 北京大学药学院天然药物及仿生药物全国重点实验室汪贻广教授团队在国际知名学术期刊Journal of the American Chemical Society上发表了题为“Lysosome-Mitochondria Cascade Targeting Nanoparticle Drives Robust Pyroptosis for Cancer Immunotherapy”的研究工作。

Supporting:

北京大学药学院天然药物及仿生药物全国重点实验室. 汪贻广/陈斌龙团队开发一种溶酶体-线粒体级联靶向纳米策略高效调控肿瘤焦亡[J]. 中国药学(英文版), 2025, 34(2): 188-189.

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research teams of Prof. Yiguang Wang/Prof. Binlong Chen have developed lysosome-mitochondria cascade targeting nanoparticle drives robust pyroptosis for cancer immunotherapy[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(2): 188-189.